Reaching your maintenance dose of tirzepatide: the facts

The myth: everyone's maintenance dose is 15mg

The most common misunderstanding is that 15mg is the target and anything less means treatment is incomplete. It is not. The 15mg strength is the licensed maximum, studied in SURMOUNT-1 where the highest dose group achieved around 20–21% average body-weight reduction over 72 weeks, a figure worth knowing, but one that belongs to a group average rather than a personal benchmark.

In practice, plenty of people reach a stable, effective place at 5mg, 7.5mg, or 10mg. The prescriber's job is to titrate upward only as far as is clinically useful and well-tolerated. If side effects persist at a given step, the next increase waits. If appetite suppression, weight trajectory and tolerability are all satisfactory at 10mg, there may be no reason to push to 12.5mg at all. Mounjaro's licensed titration schedule is designed to flex around the individual, not march everyone to the top rung regardless of how they feel.

The NICE appraisal of tirzepatide (TA1026) does include a review point: if a patient achieves less than 5% weight loss after six months at their highest tolerated dose, continuing treatment is reassessed. That is a floor, not an expectation, the majority of people in trials achieved meaningful results at various dose levels.

What 'maintenance' actually looks like in practice

Once you have been stable at a dose for several weeks, appetite suppression feels more consistent, gastrointestinal symptoms (nausea, loose stools, reflux) have largely settled, and weight change has reached a plateau or a comfortable pace, that is what maintenance feels like from the inside. If you want to understand what reaching that stable point involves, our page on the Mounjaro maintenance dose walks through how that stage is identified and managed. The maintenance dosing phase is not marked by a single event; it is a clinical judgement call made by your prescriber, usually confirmed over one to two repeat review cycles.

Practical timing matters here. If your next pen is due and you are, say, travelling, away at Christmas, or waiting for payday, the SmPC provides specific guidance on what to do if a dose is late or missed, always check the Patient Information Leaflet or speak to your prescriber rather than improvising. Common questions about repeat orders and timing are answered on our FAQs page.

At maintenance, the focus of clinical reviews shifts slightly: from 'is the next increase appropriate?' to 'is this dose still working, are you tolerating it well, and is the lifestyle programme still in place?' Blood-pressure checks, weight data and any new symptoms all feed into that conversation. If you are on tirzepatide through a private service, those reviews happen before each repeat supply, that is a requirement, not optional. Our dedicated page explaining what a maintenance dose of tirzepatide means covers how prescribers make that ongoing judgement in more detail, and if you are curious about the specifics of how doses are selected and sustained over time, our guide to maintenance dosing for tirzepatide sets out the clinical reasoning behind those decisions.

Side effects during dose increases versus steady state

One thing our prescribers hear regularly: people worry that the nausea they felt during a dose step means maintenance will always feel that rough. It usually does not. Gastrointestinal side effects (nausea, vomiting, constipation, loose stools, heartburn) tend to peak in the days following each increase and ease as your body adjusts. At a stable maintenance dose, most people find the GI picture considerably calmer than it was during titration.

That said, side effects do not vanish entirely for everyone. If you are experiencing persistent or severe symptoms at any dose, speak to your prescriber before assuming this is normal. The NHS tirzepatide page lists the recognised side-effect profile and the signs that need prompt attention. One sign that always warrants urgent medical help is severe stomach pain that radiates to the back, which can indicate pancreatitis, a rare but serious complication flagged in MHRA safety guidance.

The lower doses covered in our guide to the 5mg pen may be relevant if you are wondering whether a modest maintenance dose can still be clinically meaningful. The short answer is yes, for many people it can.

Private treatment and what happens at each review

If you are accessing tirzepatide privately, every repeat supply should involve a clinical review, not a checkbox exercise, but a genuine assessment of progress, any new symptoms, and whether the current dose remains appropriate. At nume, a GPhC-registered Independent Prescriber reads every consultation personally. There is no algorithm deciding your next dose.

Costs are worth factoring in realistically at the maintenance stage, since a higher-dose pen carries a higher price. You can see what Mounjaro costs by strength if you want to understand the financial picture before committing to a particular titration path, though the prescriber, not price, should ultimately guide that decision. If you are weighing up your options, the weight-loss treatments page explains the full clinical pathway and what a free consultation with our prescribers involves.